Home Cart 0 Sign in  
X

[ CAS No. 14924-53-9 ] {[proInfo.proName]}

,{[proInfo.pro_purity]}
Cat. No.: {[proInfo.prAm]}
HazMat Fee +

There will be a HazMat fee per item when shipping a dangerous goods. The HazMat fee will be charged to your UPS/DHL/FedEx collect account or added to the invoice unless the package is shipped via Ground service. Ship by air in Excepted Quantity (each bottle), which is up to 1g/1mL for class 6.1 packing group I or II, and up to 25g/25ml for all other HazMat items.

Type HazMat fee for 500 gram (Estimated)
Excepted Quantity USD 0.00
Limited Quantity USD 15-60
Inaccessible (Haz class 6.1), Domestic USD 80+
Inaccessible (Haz class 6.1), International USD 150+
Accessible (Haz class 3, 4, 5 or 8), Domestic USD 100+
Accessible (Haz class 3, 4, 5 or 8), International USD 200+
3d Animation Molecule Structure of 14924-53-9
Chemical Structure| 14924-53-9
Chemical Structure| 14924-53-9
Structure of 14924-53-9 * Storage: {[proInfo.prStorage]}
Cart0 Add to My Favorites Add to My Favorites Bulk Inquiry Inquiry Add To Cart

Quality Control of [ 14924-53-9 ]

Related Doc. of [ 14924-53-9 ]

Alternatived Products of [ 14924-53-9 ]

Product Details of [ 14924-53-9 ]

CAS No. :14924-53-9 MDL No. :MFCD00001321
Formula : C7H12O2 Boiling Point : -
Linear Structure Formula :- InChI Key :SMVBADCAMQOTOV-UHFFFAOYSA-N
M.W : 128.17 Pubchem ID :84700
Synonyms :

Calculated chemistry of [ 14924-53-9 ]

Physicochemical Properties

Num. heavy atoms : 9
Num. arom. heavy atoms : 0
Fraction Csp3 : 0.86
Num. rotatable bonds : 3
Num. H-bond acceptors : 2.0
Num. H-bond donors : 0.0
Molar Refractivity : 34.93
TPSA : 26.3 Ų

Pharmacokinetics

GI absorption : High
BBB permeant : Yes
P-gp substrate : No
CYP1A2 inhibitor : No
CYP2C19 inhibitor : No
CYP2C9 inhibitor : No
CYP2D6 inhibitor : No
CYP3A4 inhibitor : No
Log Kp (skin permeation) : -6.03 cm/s

Lipophilicity

Log Po/w (iLOGP) : 2.26
Log Po/w (XLOGP3) : 1.48
Log Po/w (WLOGP) : 1.35
Log Po/w (MLOGP) : 1.23
Log Po/w (SILICOS-IT) : 1.53
Consensus Log Po/w : 1.57

Druglikeness

Lipinski : 0.0
Ghose : None
Veber : 0.0
Egan : 0.0
Muegge : 1.0
Bioavailability Score : 0.55

Water Solubility

Log S (ESOL) : -1.37
Solubility : 5.48 mg/ml ; 0.0428 mol/l
Class : Very soluble
Log S (Ali) : -1.64
Solubility : 2.94 mg/ml ; 0.0229 mol/l
Class : Very soluble
Log S (SILICOS-IT) : -1.2
Solubility : 8.09 mg/ml ; 0.0631 mol/l
Class : Soluble

Medicinal Chemistry

PAINS : 0.0 alert
Brenk : 0.0 alert
Leadlikeness : 1.0
Synthetic accessibility : 1.57

Safety of [ 14924-53-9 ]

Signal Word:Danger Class:3
Precautionary Statements:P210-P403+P235 UN#:3272
Hazard Statements:H225 Packing Group:
GHS Pictogram:

Application In Synthesis of [ 14924-53-9 ]

* All experimental methods are cited from the reference, please refer to the original source for details. We do not guarantee the accuracy of the content in the reference.

  • Upstream synthesis route of [ 14924-53-9 ]
  • Downstream synthetic route of [ 14924-53-9 ]

[ 14924-53-9 ] Synthesis Path-Upstream   1~5

  • 1
  • [ 7646-66-4 ]
  • [ 14924-53-9 ]
  • [ 1193-30-2 ]
Reference: [1] Chemische Berichte, 1981, vol. 114, # 1, p. 32 - 48
  • 2
  • [ 14924-53-9 ]
  • [ 32936-76-8 ]
Reference: [1] Journal of the American Chemical Society, 2013, vol. 135, # 16, p. 6030 - 6032
  • 3
  • [ 29820-55-1 ]
  • [ 7452-79-1 ]
  • [ 539-82-2 ]
  • [ 14924-53-9 ]
  • [ 71441-76-4 ]
Reference: [1] Liebigs Annalen der Chemie, 1985, # 7, p. 1485 - 1491
  • 4
  • [ 14924-53-9 ]
  • [ 74-88-4 ]
  • [ 65338-28-5 ]
Reference: [1] Patent: WO2007/6716, 2007, A1, . Location in patent: Page/Page column 57
[2] Patent: WO2006/41797, 2006, A2, . Location in patent: Page/Page column 48
[3] Patent: WO2007/6714, 2007, A1, . Location in patent: Page/Page column 118-119
[4] Patent: WO2013/19828, 2013, A1, . Location in patent: Page/Page column 96-97
[5] Journal of the American Chemical Society, 2013, vol. 135, # 16, p. 6030 - 6032
[6] Patent: WO2013/184985, 2013, A1, . Location in patent: Paragraph 00265
[7] ACS Medicinal Chemistry Letters, 2017, vol. 8, # 2, p. 256 - 260
  • 5
  • [ 14924-53-9 ]
  • [ 35120-18-4 ]
YieldReaction ConditionsOperation in experiment
77%
Stage #1: With lithium diisopropyl amide In tetrahydrofuran at -78 - -60℃; for 1 h; Inert atmosphere
Stage #2: With carbon tetrabromide In tetrahydrofuran at -70 - 20℃;
To a 20-L 4-necked round-bottom flask, purged and maintained with an inert atmosphere of nitrogen, was placed LDA solution in THF (1 M) (2295 mL, 1.10 equiv) followed by the addition of a solution of ethyl cyclobutanecarboxylate (500 g, 3.90 mol, 1.00 equiv) in tetrahydrofuran (2.5 L) dropwise with stirring at -78°C. The mixture was stirred at -60°C for 1 h. To this was added a solution of tetrabromomethane (1250 g, 3.77 mol, 1.00 equiv) in tetrahydrofuran (1250 mL) dropwise with stirring. The resulting solution was stirred overnight from -70°C to room temperature, quenched by the addition of 600 mL of saturated aqueous NH4C1 at -10°C, and extracted with 3x800 mL of ethyl acetate. The combined organic layers were washed with 2x500 mL of brine, dried over anhydrous sodium sulfate and concentrated under vacuum. The residue was applied onto a silica gel column eluted with ethyl acetate/petroleum ether (1 :50) to afford 620 g (77percent) of ethyl 1- bromocyclobutane-l -carboxylate as light yellow oil.
40% With N-Bromosuccinimide; 2,2'-azobis(isobutyronitrile) In tetrachloromethane at 25 - 80℃; for 16 h; N-Bromosuccinimide (17.2 g, 96.6 mmol) and AIBN (1.28 g, 7.8 mmol) were added sequentially to a solution of ethyl cyclobutanecarboxylate (10.0 g, 78.0 mmol) in CC14 (140 mL) at 25°C. The reaction mixture was heated to 80°C and was maintained at that temperature for 16h whereupon TLC analysis showed that the desired product was formed (3percent EtOAc in petroleum ether, Rf = 0.4). The mixture was cooled to room temperature then was diluted with DCM (100 mL) and washed with water (100 mL x 2) and brine (100 mL). The organic layer was dried over Na2SO4, filtered, and was concentrated. The residue was purified by flash column chromatography (1-3percent EtOAc in petroleum ether) to afford compound A16 (6.4 g,40percent) as colorless oil, which was used without additional characterization.
10 mg With N-Bromosuccinimide; 2,2'-azobis(isobutyronitrile) In tetrachloromethane at 80℃; for 2 h; Description 62Ethyl 1-bromocyclo butanecarboxylate (D62)To a solution of ethyl cyclobutanecarboxylate (10 g) in Cd4 (100 mL) was added NBS (20.83 g)and AIBN (1.281 g). The mixture was stirred at 80°C for 2 hours. Water (50 mL) was added andthe mixture was extracted with EtOAc (3 x50 mL). The combined organic was washed with saturated NaHCO3 (50 mL), water (50 mL) and brine (50 mL), dried over MgSO4 and evaporated. The residue was purified by column chromatography (silica gel, petroleum ether/EtOAc = 100:1) to afford the title compound (10 g) as yellow oil. ‘H NMR (400 MHz, CDC13): 4.26 (q, J 14.4, 7.2Hz, 2H), 2.95-2.88 (m, 2H), 2.67-2.59 (m, 2H), 2.26-2.21 (m, 1H), 1.91-1.86 (m, 1H), 1.32 (t,J=7.2 Hz, 3H).
Reference: [1] Journal of Organic Chemistry, 2012, vol. 77, # 23, p. 11002 - 11005
[2] Chemical Communications, 2015, vol. 51, # 42, p. 8773 - 8776
[3] Organic Letters, 2016, vol. 18, # 9, p. 2040 - 2043
[4] Patent: WO2018/15411, 2018, A1, . Location in patent: Paragraph 0165; 0166; 0167; 0168; 0169; 0170
[5] ACS Medicinal Chemistry Letters, 2016, vol. 7, # 11, p. 988 - 993
[6] Patent: WO2017/64675, 2017, A1, . Location in patent: Page/Page column 119; 124; 125
[7] Patent: WO2015/180612, 2015, A1, . Location in patent: Page/Page column 59
[8] Organic and Biomolecular Chemistry, 2018, vol. 16, # 4, p. 521 - 525
Same Skeleton Products
Historical Records

Related Functional Groups of
[ 14924-53-9 ]

Aliphatic Cyclic Hydrocarbons

Chemical Structure| 99769-39-8

[ 99769-39-8 ]

Ethyl 3-methylcyclobutanecarboxylate

Similarity: 1.00

Chemical Structure| 1255098-89-5

[ 1255098-89-5 ]

Ethyl spiro[3.3]heptane-2-carboxylate

Similarity: 0.97

Chemical Structure| 1823373-90-5

[ 1823373-90-5 ]

3-(Ethoxycarbonyl)bicyclo[1.1.1]pentane-1-carboxylic acid

Similarity: 0.97

Chemical Structure| 132616-34-3

[ 132616-34-3 ]

Diethyl spiro[3.3]heptane-2,6-dicarboxylate

Similarity: 0.97

Chemical Structure| 99769-39-8

[ 99769-39-8 ]

Ethyl 3-methylcyclobutanecarboxylate

Similarity: 1.00

Esters

Chemical Structure| 99769-39-8

[ 99769-39-8 ]

Ethyl 3-methylcyclobutanecarboxylate

Similarity: 1.00

Chemical Structure| 1255098-89-5

[ 1255098-89-5 ]

Ethyl spiro[3.3]heptane-2-carboxylate

Similarity: 0.97

Chemical Structure| 1823373-90-5

[ 1823373-90-5 ]

3-(Ethoxycarbonyl)bicyclo[1.1.1]pentane-1-carboxylic acid

Similarity: 0.97

Chemical Structure| 132616-34-3

[ 132616-34-3 ]

Diethyl spiro[3.3]heptane-2,6-dicarboxylate

Similarity: 0.97

Chemical Structure| 99769-39-8

[ 99769-39-8 ]

Ethyl 3-methylcyclobutanecarboxylate

Similarity: 1.00